Cannabis Bioscience International Holdings (CBIH) EBT Margin (2022 - 2025)
Historic EBT Margin for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to 380.79%.
- Cannabis Bioscience International Holdings' EBT Margin fell 3249200.0% to 380.79% in Q3 2025 from the same period last year, while for Aug 2025 it was 372.36%, marking a year-over-year decrease of 2149900.0%. This contributed to the annual value of 184.02% for FY2025, which is 733100.0% up from last year.
- As of Q3 2025, Cannabis Bioscience International Holdings' EBT Margin stood at 380.79%, which was down 3249200.0% from 679.85% recorded in Q2 2025.
- In the past 5 years, Cannabis Bioscience International Holdings' EBT Margin ranged from a high of 55.87% in Q3 2024 and a low of 1016.05% during Q1 2025
- In the last 4 years, Cannabis Bioscience International Holdings' EBT Margin had a median value of 323.53% in 2025 and averaged 408.88%.
- Per our database at Business Quant, Cannabis Bioscience International Holdings' EBT Margin skyrocketed by 4302100bps in 2024 and then plummeted by -5151600bps in 2025.
- Quarter analysis of 4 years shows Cannabis Bioscience International Holdings' EBT Margin stood at 266.27% in 2022, then grew by 27bps to 195.19% in 2023, then soared by 51bps to 95.39% in 2024, then plummeted by -299bps to 380.79% in 2025.
- Its EBT Margin was 380.79% in Q3 2025, compared to 679.85% in Q2 2025 and 1016.05% in Q1 2025.